nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—SLCO1B1—Quinidine—malaria	0.105	0.202	CbGbCtD
Ezetimibe—ABCC2—Quinidine—malaria	0.0921	0.177	CbGbCtD
Ezetimibe—CYP3A4—Clindamycin—malaria	0.0692	0.133	CbGbCtD
Ezetimibe—CYP3A4—Sulfadiazine—malaria	0.0397	0.0765	CbGbCtD
Ezetimibe—ABCB1—Quinine—malaria	0.0342	0.0657	CbGbCtD
Ezetimibe—CYP3A4—Artemether—malaria	0.0338	0.065	CbGbCtD
Ezetimibe—CYP3A4—Proguanil—malaria	0.0318	0.0611	CbGbCtD
Ezetimibe—CYP3A4—Doxycycline—malaria	0.0301	0.0579	CbGbCtD
Ezetimibe—ABCB1—Quinidine—malaria	0.03	0.0578	CbGbCtD
Ezetimibe—CYP3A4—Quinine—malaria	0.0205	0.0394	CbGbCtD
Ezetimibe—CYP3A4—Quinidine—malaria	0.018	0.0346	CbGbCtD
Ezetimibe—ABCG5—blood plasma—malaria	0.0163	0.0913	CbGeAlD
Ezetimibe—CYP3A4—Dapsone—malaria	0.0155	0.0299	CbGbCtD
Ezetimibe—ABCG8—blood plasma—malaria	0.0145	0.0813	CbGeAlD
Ezetimibe—SOAT1—Statin Pathway—SCARB1—malaria	0.00902	0.0914	CbGpPWpGaD
Ezetimibe—ABCG5—hematopoietic system—malaria	0.00901	0.0505	CbGeAlD
Ezetimibe—NPC1L1—hematopoietic system—malaria	0.00847	0.0474	CbGeAlD
Ezetimibe—ABCG8—hematopoietic system—malaria	0.00803	0.045	CbGeAlD
Ezetimibe—ANPEP—Glutathione metabolism—G6PD—malaria	0.00757	0.0768	CbGpPWpGaD
Ezetimibe—ABCG5—digestive system—malaria	0.00626	0.0351	CbGeAlD
Ezetimibe—NPC1L1—digestive system—malaria	0.00589	0.033	CbGeAlD
Ezetimibe—NPC1L1—blood—malaria	0.00561	0.0314	CbGeAlD
Ezetimibe—ABCG8—digestive system—malaria	0.00558	0.0313	CbGeAlD
Ezetimibe—ABCG8—blood—malaria	0.00532	0.0298	CbGeAlD
Ezetimibe—ABCG8—Statin Pathway—SCARB1—malaria	0.00474	0.048	CbGpPWpGaD
Ezetimibe—ABCG5—liver—malaria	0.00467	0.0261	CbGeAlD
Ezetimibe—NPC1L1—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00456	0.0463	CbGpPWpGaD
Ezetimibe—ABCG5—Statin Pathway—SCARB1—malaria	0.00456	0.0462	CbGpPWpGaD
Ezetimibe—NPC1L1—liver—malaria	0.00439	0.0246	CbGeAlD
Ezetimibe—ABCG8—liver—malaria	0.00416	0.0233	CbGeAlD
Ezetimibe—NPC1L1—Lipid and lipoprotein metabolism—SCARB1—malaria	0.00404	0.041	CbGpPWpGaD
Ezetimibe—ABCG8—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00346	0.0351	CbGpPWpGaD
Ezetimibe—ABCG5—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00333	0.0337	CbGpPWpGaD
Ezetimibe—UGT1A1—blood plasma—malaria	0.00317	0.0177	CbGeAlD
Ezetimibe—ABCG8—Lipid and lipoprotein metabolism—SCARB1—malaria	0.00306	0.0311	CbGpPWpGaD
Ezetimibe—SOAT1—saliva-secreting gland—malaria	0.00304	0.017	CbGeAlD
Ezetimibe—ABCG5—Lipid and lipoprotein metabolism—SCARB1—malaria	0.00295	0.0299	CbGpPWpGaD
Ezetimibe—ANPEP—saliva-secreting gland—malaria	0.00291	0.0163	CbGeAlD
Ezetimibe—SOAT1—hematopoietic system—malaria	0.0029	0.0162	CbGeAlD
Ezetimibe—NPC1L1—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00286	0.029	CbGpPWpGaD
Ezetimibe—ANPEP—hematopoietic system—malaria	0.00277	0.0155	CbGeAlD
Ezetimibe—SLCO1B1—blood plasma—malaria	0.00264	0.0148	CbGeAlD
Ezetimibe—ABCC3—blood plasma—malaria	0.0025	0.014	CbGeAlD
Ezetimibe—UGT1A3—digestive system—malaria	0.00249	0.014	CbGeAlD
Ezetimibe—UGT2B15—digestive system—malaria	0.00234	0.0131	CbGeAlD
Ezetimibe—ANPEP—kidney—malaria	0.00227	0.0127	CbGeAlD
Ezetimibe—ABCG8—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00217	0.022	CbGpPWpGaD
Ezetimibe—ABCG5—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00209	0.0212	CbGpPWpGaD
Ezetimibe—SOAT1—digestive system—malaria	0.00202	0.0113	CbGeAlD
Ezetimibe—ANPEP—digestive system—malaria	0.00193	0.0108	CbGeAlD
Ezetimibe—SOAT1—blood—malaria	0.00192	0.0108	CbGeAlD
Ezetimibe—SOAT1—bone marrow—malaria	0.00186	0.0104	CbGeAlD
Ezetimibe—UGT1A3—liver—malaria	0.00186	0.0104	CbGeAlD
Ezetimibe—ANPEP—blood—malaria	0.00184	0.0103	CbGeAlD
Ezetimibe—ANPEP—bone marrow—malaria	0.00178	0.00996	CbGeAlD
Ezetimibe—UGT1A1—hematopoietic system—malaria	0.00175	0.00981	CbGeAlD
Ezetimibe—UGT2B15—liver—malaria	0.00175	0.00979	CbGeAlD
Ezetimibe—UGT2B7—kidney—malaria	0.00169	0.00946	CbGeAlD
Ezetimibe—SOAT1—liver—malaria	0.0015	0.00842	CbGeAlD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—KDR—malaria	0.00147	0.015	CbGpPWpGaD
Ezetimibe—SLCO1B1—hematopoietic system—malaria	0.00146	0.00816	CbGeAlD
Ezetimibe—ANPEP—liver—malaria	0.00144	0.00805	CbGeAlD
Ezetimibe—UGT1A1—kidney—malaria	0.00144	0.00804	CbGeAlD
Ezetimibe—UGT2B7—digestive system—malaria	0.00143	0.00802	CbGeAlD
Ezetimibe—ABCC3—hematopoietic system—malaria	0.00138	0.00775	CbGeAlD
Ezetimibe—UGT1A1—digestive system—malaria	0.00122	0.00682	CbGeAlD
Ezetimibe—UGT2B15—Phase II conjugation—HPGDS—malaria	0.0012	0.0121	CbGpPWpGaD
Ezetimibe—SLCO1B1—kidney—malaria	0.00119	0.00669	CbGeAlD
Ezetimibe—SOAT1—brain—malaria	0.00119	0.00668	CbGeAlD
Ezetimibe—UGT1A1—blood—malaria	0.00116	0.0065	CbGeAlD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.00115	0.0116	CbGpPWpGaD
Ezetimibe—ANPEP—brain—malaria	0.00114	0.00639	CbGeAlD
Ezetimibe—ABCC3—kidney—malaria	0.00113	0.00635	CbGeAlD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—DHFR—malaria	0.00111	0.0112	CbGpPWpGaD
Ezetimibe—UGT2B7—liver—malaria	0.00107	0.00598	CbGeAlD
Ezetimibe—CYP3A4—blood plasma—malaria	0.00102	0.00569	CbGeAlD
Ezetimibe—SLCO1B1—digestive system—malaria	0.00101	0.00568	CbGeAlD
Ezetimibe—ANPEP—Metabolism of proteins—NANP—malaria	0.000981	0.00995	CbGpPWpGaD
Ezetimibe—SLCO1B1—blood—malaria	0.000966	0.00541	CbGeAlD
Ezetimibe—Pancreatitis—Dapsone—malaria	0.000964	0.00474	CcSEcCtD
Ezetimibe—ABCC3—digestive system—malaria	0.000962	0.00539	CbGeAlD
Ezetimibe—Muscular weakness—Quinidine—malaria	0.000952	0.00468	CcSEcCtD
Ezetimibe—Muscular weakness—Quinine—malaria	0.000952	0.00468	CcSEcCtD
Ezetimibe—Decreased appetite—Proguanil—malaria	0.000951	0.00468	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Proguanil—malaria	0.000944	0.00464	CcSEcCtD
Ezetimibe—Eosinophilia—Clindamycin—malaria	0.000941	0.00463	CcSEcCtD
Ezetimibe—ABCC3—blood—malaria	0.000916	0.00513	CbGeAlD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000909	0.00922	CbGpPWpGaD
Ezetimibe—UGT1A1—liver—malaria	0.000907	0.00508	CbGeAlD
Ezetimibe—ABCC2—kidney—malaria	0.000906	0.00507	CbGeAlD
Ezetimibe—Liver function test abnormal—Quinidine barbiturate—malaria	0.000899	0.00442	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Dapsone—malaria	0.000897	0.00441	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Proguanil—malaria	0.000894	0.0044	CcSEcCtD
Ezetimibe—Vomiting—Pyrimethamine—malaria	0.000893	0.00439	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Clindamycin—malaria	0.000884	0.00435	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC4A1—malaria	0.00088	0.00893	CbGpPWpGaD
Ezetimibe—Breast disorder—Quinidine barbiturate—malaria	0.00088	0.00433	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—DECR1—malaria	0.00087	0.00883	CbGpPWpGaD
Ezetimibe—Photosensitivity reaction—Clindamycin—malaria	0.000868	0.00427	CcSEcCtD
Ezetimibe—Abdominal pain—Proguanil—malaria	0.000865	0.00425	CcSEcCtD
Ezetimibe—Body temperature increased—Proguanil—malaria	0.000865	0.00425	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Dapsone—malaria	0.000859	0.00422	CcSEcCtD
Ezetimibe—Muscular weakness—Quinidine barbiturate—malaria	0.000859	0.00422	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Quinidine—malaria	0.000851	0.00419	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Quinine—malaria	0.000851	0.00419	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC4A1—malaria	0.000847	0.00859	CbGpPWpGaD
Ezetimibe—ABCG2—saliva-secreting gland—malaria	0.000844	0.00473	CbGeAlD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000838	0.0085	CbGpPWpGaD
Ezetimibe—Jaundice—Clindamycin—malaria	0.000826	0.00406	CcSEcCtD
Ezetimibe—Sinusitis—Dapsone—malaria	0.000822	0.00404	CcSEcCtD
Ezetimibe—Jaundice—Quinidine—malaria	0.000811	0.00399	CcSEcCtD
Ezetimibe—Jaundice—Quinine—malaria	0.000811	0.00399	CcSEcCtD
Ezetimibe—Pharyngitis—Dapsone—malaria	0.000781	0.00384	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Quinidine barbiturate—malaria	0.000768	0.00378	CcSEcCtD
Ezetimibe—ABCC2—digestive system—malaria	0.000768	0.0043	CbGeAlD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—DHFR—malaria	0.000763	0.00774	CbGpPWpGaD
Ezetimibe—Arthralgia—Sulfadiazine—malaria	0.000757	0.00372	CcSEcCtD
Ezetimibe—SLCO1B1—liver—malaria	0.000755	0.00423	CbGeAlD
Ezetimibe—Infestation—Pentoxifylline—malaria	0.000749	0.00368	CcSEcCtD
Ezetimibe—Infestation NOS—Pentoxifylline—malaria	0.000749	0.00368	CcSEcCtD
Ezetimibe—Diarrhoea—Proguanil—malaria	0.000748	0.00368	CcSEcCtD
Ezetimibe—Hepatitis—Quinine—malaria	0.000747	0.00367	CcSEcCtD
Ezetimibe—Hepatitis—Quinidine—malaria	0.000747	0.00367	CcSEcCtD
Ezetimibe—ABCC2—blood—malaria	0.000732	0.0041	CbGeAlD
Ezetimibe—Jaundice—Quinidine barbiturate—malaria	0.000732	0.0036	CcSEcCtD
Ezetimibe—Jaundice—Pentoxifylline—malaria	0.00073	0.00359	CcSEcCtD
Ezetimibe—Anaphylactic shock—Sulfadiazine—malaria	0.000726	0.00357	CcSEcCtD
Ezetimibe—Erythema multiforme—Clindamycin—malaria	0.00072	0.00354	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—CD4—malaria	0.000719	0.00729	CbGpPWpGaD
Ezetimibe—ABCB1—blood plasma—malaria	0.000719	0.00402	CbGeAlD
Ezetimibe—ABCC3—liver—malaria	0.000716	0.00401	CbGeAlD
Ezetimibe—Thrombocytopenia—Sulfadiazine—malaria	0.000711	0.0035	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Pentoxifylline—malaria	0.000709	0.00348	CcSEcCtD
Ezetimibe—Flushing—Clindamycin—malaria	0.000706	0.00347	CcSEcCtD
Ezetimibe—Erythema multiforme—Quinidine—malaria	0.000706	0.00347	CcSEcCtD
Ezetimibe—Erythema multiforme—Quinine—malaria	0.000706	0.00347	CcSEcCtD
Ezetimibe—UGT2B15—Biological oxidations—HPGDS—malaria	0.000699	0.00709	CbGpPWpGaD
Ezetimibe—Vomiting—Proguanil—malaria	0.000695	0.00342	CcSEcCtD
Ezetimibe—Flushing—Quinine—malaria	0.000693	0.00341	CcSEcCtD
Ezetimibe—Flushing—Quinidine—malaria	0.000693	0.00341	CcSEcCtD
Ezetimibe—Rash—Proguanil—malaria	0.00069	0.00339	CcSEcCtD
Ezetimibe—Dermatitis—Proguanil—malaria	0.000689	0.00339	CcSEcCtD
Ezetimibe—Headache—Proguanil—malaria	0.000685	0.00337	CcSEcCtD
Ezetimibe—Erythema—Dapsone—malaria	0.000685	0.00337	CcSEcCtD
Ezetimibe—Immune system disorder—Quinidine—malaria	0.000674	0.00332	CcSEcCtD
Ezetimibe—Immune system disorder—Quinine—malaria	0.000674	0.00332	CcSEcCtD
Ezetimibe—Hepatitis—Quinidine barbiturate—malaria	0.000674	0.00331	CcSEcCtD
Ezetimibe—Mediastinal disorder—Quinine—malaria	0.000673	0.00331	CcSEcCtD
Ezetimibe—Mediastinal disorder—Quinidine—malaria	0.000673	0.00331	CcSEcCtD
Ezetimibe—Hepatitis—Pentoxifylline—malaria	0.000673	0.00331	CcSEcCtD
Ezetimibe—Erythema—Clindamycin—malaria	0.000662	0.00326	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000662	0.00325	CcSEcCtD
Ezetimibe—Insomnia—Sulfadiazine—malaria	0.000657	0.00323	CcSEcCtD
Ezetimibe—Mental disorder—Quinine—malaria	0.000654	0.00322	CcSEcCtD
Ezetimibe—Mental disorder—Quinidine—malaria	0.000654	0.00322	CcSEcCtD
Ezetimibe—Flatulence—Clindamycin—malaria	0.000653	0.00321	CcSEcCtD
Ezetimibe—Erythema—Quinidine—malaria	0.00065	0.0032	CcSEcCtD
Ezetimibe—Erythema—Quinine—malaria	0.00065	0.0032	CcSEcCtD
Ezetimibe—Malnutrition—Quinidine—malaria	0.00065	0.0032	CcSEcCtD
Ezetimibe—Malnutrition—Quinine—malaria	0.00065	0.0032	CcSEcCtD
Ezetimibe—Nausea—Proguanil—malaria	0.00065	0.00319	CcSEcCtD
Ezetimibe—Back pain—Clindamycin—malaria	0.000641	0.00315	CcSEcCtD
Ezetimibe—UGT1A3—Phase II conjugation—HPGDS—malaria	0.00064	0.0065	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—DHODH—malaria	0.00064	0.00649	CbGpPWpGaD
Ezetimibe—Erythema multiforme—Quinidine barbiturate—malaria	0.000637	0.00313	CcSEcCtD
Ezetimibe—Muscle spasms—Clindamycin—malaria	0.000637	0.00313	CcSEcCtD
Ezetimibe—Decreased appetite—Sulfadiazine—malaria	0.000631	0.0031	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000629	0.00638	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000628	0.00637	CbGpPWpGaD
Ezetimibe—Gastrointestinal disorder—Sulfadiazine—malaria	0.000627	0.00308	CcSEcCtD
Ezetimibe—Flushing—Quinidine barbiturate—malaria	0.000625	0.00307	CcSEcCtD
Ezetimibe—Flushing—Pentoxifylline—malaria	0.000624	0.00307	CcSEcCtD
Ezetimibe—Anaemia—Clindamycin—malaria	0.000612	0.00301	CcSEcCtD
Ezetimibe—Immune system disorder—Quinidine barbiturate—malaria	0.000609	0.00299	CcSEcCtD
Ezetimibe—Immune system disorder—Pentoxifylline—malaria	0.000607	0.00299	CcSEcCtD
Ezetimibe—Mediastinal disorder—Quinidine barbiturate—malaria	0.000607	0.00299	CcSEcCtD
Ezetimibe—Cough—Dapsone—malaria	0.000598	0.00294	CcSEcCtD
Ezetimibe—Angioedema—Quinidine—malaria	0.000594	0.00292	CcSEcCtD
Ezetimibe—Angioedema—Quinine—malaria	0.000594	0.00292	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Sulfadiazine—malaria	0.000594	0.00292	CcSEcCtD
Ezetimibe—Mental disorder—Quinidine barbiturate—malaria	0.00059	0.0029	CcSEcCtD
Ezetimibe—Erythema—Quinidine barbiturate—malaria	0.000587	0.00288	CcSEcCtD
Ezetimibe—Malnutrition—Quinidine barbiturate—malaria	0.000587	0.00288	CcSEcCtD
Ezetimibe—Erythema—Pentoxifylline—malaria	0.000585	0.00288	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000578	0.00586	CbGpPWpGaD
Ezetimibe—Flatulence—Pentoxifylline—malaria	0.000577	0.00284	CcSEcCtD
Ezetimibe—Urticaria—Sulfadiazine—malaria	0.000577	0.00284	CcSEcCtD
Ezetimibe—Palpitations—Quinine—malaria	0.000574	0.00282	CcSEcCtD
Ezetimibe—Palpitations—Quinidine—malaria	0.000574	0.00282	CcSEcCtD
Ezetimibe—Body temperature increased—Sulfadiazine—malaria	0.000574	0.00282	CcSEcCtD
Ezetimibe—Abdominal pain—Sulfadiazine—malaria	0.000574	0.00282	CcSEcCtD
Ezetimibe—ABCC2—liver—malaria	0.000572	0.00321	CbGeAlD
Ezetimibe—Hypertension—Clindamycin—malaria	0.000572	0.00281	CcSEcCtD
Ezetimibe—ABCC3—brain—malaria	0.000568	0.00318	CbGeAlD
Ezetimibe—Back pain—Pentoxifylline—malaria	0.000566	0.00278	CcSEcCtD
Ezetimibe—Muscle spasms—Pentoxifylline—malaria	0.000563	0.00277	CcSEcCtD
Ezetimibe—CYP3A4—hematopoietic system—malaria	0.000561	0.00314	CbGeAlD
Ezetimibe—UGT1A3—NRF2 pathway—G6PD—malaria	0.00056	0.00568	CbGpPWpGaD
Ezetimibe—Discomfort—Clindamycin—malaria	0.000557	0.00274	CcSEcCtD
Ezetimibe—Chest pain—Quinine—malaria	0.000553	0.00272	CcSEcCtD
Ezetimibe—Myalgia—Quinidine—malaria	0.000553	0.00272	CcSEcCtD
Ezetimibe—Chest pain—Quinidine—malaria	0.000553	0.00272	CcSEcCtD
Ezetimibe—Myalgia—Quinine—malaria	0.000553	0.00272	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000549	0.0027	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000549	0.0027	CcSEcCtD
Ezetimibe—UGT2B7—Phase II conjugation—HPGDS—malaria	0.000545	0.00552	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—SLC4A1—malaria	0.000544	0.00552	CbGpPWpGaD
Ezetimibe—Ill-defined disorder—Pentoxifylline—malaria	0.000543	0.00267	CcSEcCtD
Ezetimibe—Anaemia—Pentoxifylline—malaria	0.000541	0.00266	CcSEcCtD
Ezetimibe—Anaphylactic shock—Clindamycin—malaria	0.000541	0.00266	CcSEcCtD
Ezetimibe—Angioedema—Quinidine barbiturate—malaria	0.000536	0.00264	CcSEcCtD
Ezetimibe—Angioedema—Pentoxifylline—malaria	0.000535	0.00263	CcSEcCtD
Ezetimibe—Hypersensitivity—Sulfadiazine—malaria	0.000535	0.00263	CcSEcCtD
Ezetimibe—Confusional state—Quinidine—malaria	0.000535	0.00263	CcSEcCtD
Ezetimibe—Confusional state—Quinine—malaria	0.000535	0.00263	CcSEcCtD
Ezetimibe—ABCG2—blood—malaria	0.000534	0.00299	CbGeAlD
Ezetimibe—Thrombocytopenia—Clindamycin—malaria	0.000529	0.0026	CcSEcCtD
Ezetimibe—Malaise—Pentoxifylline—malaria	0.000528	0.0026	CcSEcCtD
Ezetimibe—Nervous system disorder—Quinine—malaria	0.00052	0.00256	CcSEcCtD
Ezetimibe—Nervous system disorder—Quinidine—malaria	0.00052	0.00256	CcSEcCtD
Ezetimibe—Thrombocytopenia—Quinidine—malaria	0.000519	0.00255	CcSEcCtD
Ezetimibe—Thrombocytopenia—Quinine—malaria	0.000519	0.00255	CcSEcCtD
Ezetimibe—Palpitations—Quinidine barbiturate—malaria	0.000518	0.00255	CcSEcCtD
Ezetimibe—Palpitations—Pentoxifylline—malaria	0.000517	0.00254	CcSEcCtD
Ezetimibe—ABCG2—bone marrow—malaria	0.000517	0.00289	CbGeAlD
Ezetimibe—Skin disorder—Quinidine—malaria	0.000515	0.00253	CcSEcCtD
Ezetimibe—Skin disorder—Quinine—malaria	0.000515	0.00253	CcSEcCtD
Ezetimibe—Pruritus—Sulfadiazine—malaria	0.000514	0.00253	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—DECR1—malaria	0.000511	0.00519	CbGpPWpGaD
Ezetimibe—Insomnia—Dapsone—malaria	0.000506	0.00249	CcSEcCtD
Ezetimibe—Hypertension—Pentoxifylline—malaria	0.000505	0.00249	CcSEcCtD
Ezetimibe—Arthralgia—Quinidine barbiturate—malaria	0.000499	0.00246	CcSEcCtD
Ezetimibe—Myalgia—Quinidine barbiturate—malaria	0.000499	0.00246	CcSEcCtD
Ezetimibe—Chest pain—Quinidine barbiturate—malaria	0.000499	0.00246	CcSEcCtD
Ezetimibe—Myalgia—Pentoxifylline—malaria	0.000498	0.00245	CcSEcCtD
Ezetimibe—Chest pain—Pentoxifylline—malaria	0.000498	0.00245	CcSEcCtD
Ezetimibe—Diarrhoea—Sulfadiazine—malaria	0.000497	0.00244	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000496	0.00244	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000495	0.00243	CcSEcCtD
Ezetimibe—Discomfort—Pentoxifylline—malaria	0.000492	0.00242	CcSEcCtD
Ezetimibe—Dry mouth—Pentoxifylline—malaria	0.000487	0.0024	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—DHODH—malaria	0.000485	0.00492	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Quinine—malaria	0.000483	0.00238	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Quinidine—malaria	0.000483	0.00238	CcSEcCtD
Ezetimibe—Confusional state—Quinidine barbiturate—malaria	0.000483	0.00237	CcSEcCtD
Ezetimibe—Dyspnoea—Clindamycin—malaria	0.000482	0.00237	CcSEcCtD
Ezetimibe—Confusional state—Pentoxifylline—malaria	0.000482	0.00237	CcSEcCtD
Ezetimibe—Anaphylactic shock—Pentoxifylline—malaria	0.000478	0.00235	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000477	0.00484	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—G6PD—malaria	0.000476	0.00483	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—G6PD—malaria	0.000476	0.00483	CbGpPWpGaD
Ezetimibe—Dyspepsia—Clindamycin—malaria	0.000476	0.00234	CcSEcCtD
Ezetimibe—Infection—Pentoxifylline—malaria	0.000475	0.00233	CcSEcCtD
Ezetimibe—Dyspnoea—Quinidine—malaria	0.000473	0.00233	CcSEcCtD
Ezetimibe—Dyspnoea—Quinine—malaria	0.000473	0.00233	CcSEcCtD
Ezetimibe—Nervous system disorder—Quinidine barbiturate—malaria	0.000469	0.00231	CcSEcCtD
Ezetimibe—Thrombocytopenia—Quinidine barbiturate—malaria	0.000469	0.0023	CcSEcCtD
Ezetimibe—Thrombocytopenia—Pentoxifylline—malaria	0.000468	0.0023	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Clindamycin—malaria	0.000467	0.0023	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—DHODH—malaria	0.000467	0.00473	CbGpPWpGaD
Ezetimibe—Fatigue—Clindamycin—malaria	0.000466	0.00229	CcSEcCtD
Ezetimibe—Skin disorder—Quinidine barbiturate—malaria	0.000465	0.00229	CcSEcCtD
Ezetimibe—Skin disorder—Pentoxifylline—malaria	0.000464	0.00228	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—HBB—malaria	0.000463	0.00469	CbGpPWpGaD
Ezetimibe—Constipation—Clindamycin—malaria	0.000462	0.00227	CcSEcCtD
Ezetimibe—Pain—Clindamycin—malaria	0.000462	0.00227	CcSEcCtD
Ezetimibe—Vomiting—Sulfadiazine—malaria	0.000462	0.00227	CcSEcCtD
Ezetimibe—Decreased appetite—Quinine—malaria	0.000461	0.00227	CcSEcCtD
Ezetimibe—Decreased appetite—Quinidine—malaria	0.000461	0.00227	CcSEcCtD
Ezetimibe—CYP3A4—kidney—malaria	0.00046	0.00258	CbGeAlD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000459	0.00466	CbGpPWpGaD
Ezetimibe—Gastrointestinal disorder—Quinidine—malaria	0.000458	0.00225	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Quinine—malaria	0.000458	0.00225	CcSEcCtD
Ezetimibe—Rash—Sulfadiazine—malaria	0.000458	0.00225	CcSEcCtD
Ezetimibe—Dermatitis—Sulfadiazine—malaria	0.000457	0.00225	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Dapsone—malaria	0.000457	0.00225	CcSEcCtD
Ezetimibe—Headache—Sulfadiazine—malaria	0.000455	0.00224	CcSEcCtD
Ezetimibe—UGT1A1—Phase II conjugation—HPGDS—malaria	0.000443	0.00449	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Clindamycin—malaria	0.000442	0.00217	CcSEcCtD
Ezetimibe—Body temperature increased—Dapsone—malaria	0.000442	0.00217	CcSEcCtD
Ezetimibe—Abdominal pain—Dapsone—malaria	0.000442	0.00217	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000438	0.00444	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Quinine—malaria	0.000437	0.00215	CcSEcCtD
Ezetimibe—Feeling abnormal—Quinidine—malaria	0.000437	0.00215	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000436	0.00214	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000435	0.00214	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Quinine—malaria	0.000434	0.00213	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Quinidine—malaria	0.000434	0.00213	CcSEcCtD
Ezetimibe—Insomnia—Pentoxifylline—malaria	0.000432	0.00213	CcSEcCtD
Ezetimibe—Nausea—Sulfadiazine—malaria	0.000431	0.00212	CcSEcCtD
Ezetimibe—Urticaria—Clindamycin—malaria	0.00043	0.00211	CcSEcCtD
Ezetimibe—Abdominal pain—Clindamycin—malaria	0.000427	0.0021	CcSEcCtD
Ezetimibe—Body temperature increased—Clindamycin—malaria	0.000427	0.0021	CcSEcCtD
Ezetimibe—Dyspnoea—Quinidine barbiturate—malaria	0.000427	0.0021	CcSEcCtD
Ezetimibe—Dyspnoea—Pentoxifylline—malaria	0.000426	0.00209	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000421	0.00427	CbGpPWpGaD
Ezetimibe—Urticaria—Quinine—malaria	0.000421	0.00207	CcSEcCtD
Ezetimibe—Urticaria—Quinidine—malaria	0.000421	0.00207	CcSEcCtD
Ezetimibe—Dyspepsia—Pentoxifylline—malaria	0.000421	0.00207	CcSEcCtD
Ezetimibe—Abdominal pain—Quinidine—malaria	0.000419	0.00206	CcSEcCtD
Ezetimibe—Body temperature increased—Quinine—malaria	0.000419	0.00206	CcSEcCtD
Ezetimibe—Abdominal pain—Quinine—malaria	0.000419	0.00206	CcSEcCtD
Ezetimibe—Body temperature increased—Quinidine—malaria	0.000419	0.00206	CcSEcCtD
Ezetimibe—ABCG2—liver—malaria	0.000417	0.00234	CbGeAlD
Ezetimibe—Decreased appetite—Quinidine barbiturate—malaria	0.000416	0.00205	CcSEcCtD
Ezetimibe—Decreased appetite—Pentoxifylline—malaria	0.000415	0.00204	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000413	0.00203	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—SLC4A1—malaria	0.000412	0.00418	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PKLR—malaria	0.000412	0.00418	CbGpPWpGaD
Ezetimibe—Constipation—Quinidine barbiturate—malaria	0.000409	0.00201	CcSEcCtD
Ezetimibe—Pain—Quinidine barbiturate—malaria	0.000409	0.00201	CcSEcCtD
Ezetimibe—Constipation—Pentoxifylline—malaria	0.000409	0.00201	CcSEcCtD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—KDR—malaria	0.0004	0.00406	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Clindamycin—malaria	0.000398	0.00196	CcSEcCtD
Ezetimibe—ABCB1—hematopoietic system—malaria	0.000397	0.00223	CbGeAlD
Ezetimibe—ABCG5—Metabolism—SLC4A1—malaria	0.000397	0.00402	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Quinidine barbiturate—malaria	0.000394	0.00194	CcSEcCtD
Ezetimibe—Feeling abnormal—Pentoxifylline—malaria	0.000394	0.00194	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000391	0.00192	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000391	0.00396	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Quinine—malaria	0.000391	0.00192	CcSEcCtD
Ezetimibe—Hypersensitivity—Quinidine—malaria	0.000391	0.00192	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Pentoxifylline—malaria	0.000391	0.00192	CcSEcCtD
Ezetimibe—CYP3A4—digestive system—malaria	0.00039	0.00219	CbGeAlD
Ezetimibe—Asthenia—Clindamycin—malaria	0.000388	0.00191	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—DECR1—malaria	0.000388	0.00393	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—G6PD—malaria	0.000387	0.00392	CbGpPWpGaD
Ezetimibe—Pruritus—Clindamycin—malaria	0.000383	0.00188	CcSEcCtD
Ezetimibe—Asthenia—Quinidine—malaria	0.000381	0.00187	CcSEcCtD
Ezetimibe—Asthenia—Quinine—malaria	0.000381	0.00187	CcSEcCtD
Ezetimibe—Urticaria—Quinidine barbiturate—malaria	0.00038	0.00187	CcSEcCtD
Ezetimibe—Urticaria—Pentoxifylline—malaria	0.00038	0.00187	CcSEcCtD
Ezetimibe—Body temperature increased—Quinidine barbiturate—malaria	0.000378	0.00186	CcSEcCtD
Ezetimibe—Abdominal pain—Quinidine barbiturate—malaria	0.000378	0.00186	CcSEcCtD
Ezetimibe—Body temperature increased—Pentoxifylline—malaria	0.000378	0.00186	CcSEcCtD
Ezetimibe—Abdominal pain—Pentoxifylline—malaria	0.000378	0.00186	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—G6PD—malaria	0.000378	0.00383	CbGpPWpGaD
Ezetimibe—Pruritus—Quinidine—malaria	0.000375	0.00185	CcSEcCtD
Ezetimibe—Pruritus—Quinine—malaria	0.000375	0.00185	CcSEcCtD
Ezetimibe—UGT1A3—Biological oxidations—HPGDS—malaria	0.000375	0.0038	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—DECR1—malaria	0.000373	0.00378	CbGpPWpGaD
Ezetimibe—CYP3A4—blood—malaria	0.000372	0.00208	CbGeAlD
Ezetimibe—Diarrhoea—Clindamycin—malaria	0.00037	0.00182	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—G6PD—malaria	0.000367	0.00373	CbGpPWpGaD
Ezetimibe—Diarrhoea—Quinidine—malaria	0.000363	0.00178	CcSEcCtD
Ezetimibe—Diarrhoea—Quinine—malaria	0.000363	0.00178	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—CD36—malaria	0.000363	0.00368	CbGpPWpGaD
Ezetimibe—Dizziness—Clindamycin—malaria	0.000358	0.00176	CcSEcCtD
Ezetimibe—Vomiting—Dapsone—malaria	0.000355	0.00175	CcSEcCtD
Ezetimibe—Hypersensitivity—Quinidine barbiturate—malaria	0.000353	0.00173	CcSEcCtD
Ezetimibe—Hypersensitivity—Pentoxifylline—malaria	0.000352	0.00173	CcSEcCtD
Ezetimibe—Dizziness—Quinine—malaria	0.000351	0.00172	CcSEcCtD
Ezetimibe—Dizziness—Quinidine—malaria	0.000351	0.00172	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—HBB—malaria	0.000351	0.00355	CbGpPWpGaD
Ezetimibe—Headache—Dapsone—malaria	0.00035	0.00172	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000349	0.00354	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000347	0.00352	CbGpPWpGaD
Ezetimibe—Vomiting—Clindamycin—malaria	0.000344	0.00169	CcSEcCtD
Ezetimibe—Asthenia—Quinidine barbiturate—malaria	0.000343	0.00169	CcSEcCtD
Ezetimibe—Asthenia—Pentoxifylline—malaria	0.000343	0.00169	CcSEcCtD
Ezetimibe—Rash—Clindamycin—malaria	0.000341	0.00168	CcSEcCtD
Ezetimibe—Dermatitis—Clindamycin—malaria	0.000341	0.00167	CcSEcCtD
Ezetimibe—Headache—Clindamycin—malaria	0.000339	0.00167	CcSEcCtD
Ezetimibe—Pruritus—Quinidine barbiturate—malaria	0.000339	0.00167	CcSEcCtD
Ezetimibe—Pruritus—Pentoxifylline—malaria	0.000338	0.00166	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—HBB—malaria	0.000337	0.00342	CbGpPWpGaD
Ezetimibe—Vomiting—Quinidine—malaria	0.000337	0.00166	CcSEcCtD
Ezetimibe—Vomiting—Quinine—malaria	0.000337	0.00166	CcSEcCtD
Ezetimibe—Rash—Quinidine—malaria	0.000334	0.00164	CcSEcCtD
Ezetimibe—Rash—Quinine—malaria	0.000334	0.00164	CcSEcCtD
Ezetimibe—Dermatitis—Quinidine—malaria	0.000334	0.00164	CcSEcCtD
Ezetimibe—Dermatitis—Quinine—malaria	0.000334	0.00164	CcSEcCtD
Ezetimibe—Headache—Quinine—malaria	0.000332	0.00163	CcSEcCtD
Ezetimibe—Headache—Quinidine—malaria	0.000332	0.00163	CcSEcCtD
Ezetimibe—Nausea—Dapsone—malaria	0.000332	0.00163	CcSEcCtD
Ezetimibe—ABCG2—brain—malaria	0.000331	0.00186	CbGeAlD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000331	0.00336	CbGpPWpGaD
Ezetimibe—Diarrhoea—Quinidine barbiturate—malaria	0.000328	0.00161	CcSEcCtD
Ezetimibe—Diarrhoea—Pentoxifylline—malaria	0.000327	0.00161	CcSEcCtD
Ezetimibe—ABCB1—kidney—malaria	0.000326	0.00182	CbGeAlD
Ezetimibe—Nausea—Clindamycin—malaria	0.000321	0.00158	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—HPGDS—malaria	0.000319	0.00323	CbGpPWpGaD
Ezetimibe—Dizziness—Quinidine barbiturate—malaria	0.000317	0.00156	CcSEcCtD
Ezetimibe—Dizziness—Pentoxifylline—malaria	0.000316	0.00155	CcSEcCtD
Ezetimibe—Nausea—Quinine—malaria	0.000315	0.00155	CcSEcCtD
Ezetimibe—Nausea—Quinidine—malaria	0.000315	0.00155	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—PKLR—malaria	0.000312	0.00317	CbGpPWpGaD
Ezetimibe—Vomiting—Quinidine barbiturate—malaria	0.000304	0.0015	CcSEcCtD
Ezetimibe—Vomiting—Pentoxifylline—malaria	0.000304	0.00149	CcSEcCtD
Ezetimibe—Rash—Quinidine barbiturate—malaria	0.000302	0.00148	CcSEcCtD
Ezetimibe—Dermatitis—Quinidine barbiturate—malaria	0.000302	0.00148	CcSEcCtD
Ezetimibe—Rash—Pentoxifylline—malaria	0.000301	0.00148	CcSEcCtD
Ezetimibe—Dermatitis—Pentoxifylline—malaria	0.000301	0.00148	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—PKLR—malaria	0.000301	0.00305	CbGpPWpGaD
Ezetimibe—Headache—Quinidine barbiturate—malaria	0.0003	0.00147	CcSEcCtD
Ezetimibe—Headache—Pentoxifylline—malaria	0.000299	0.00147	CcSEcCtD
Ezetimibe—CYP3A4—liver—malaria	0.000291	0.00163	CbGeAlD
Ezetimibe—Nausea—Quinidine barbiturate—malaria	0.000284	0.0014	CcSEcCtD
Ezetimibe—Nausea—Pentoxifylline—malaria	0.000284	0.0014	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—HPGDS—malaria	0.00028	0.00284	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—G6PD—malaria	0.000278	0.00282	CbGpPWpGaD
Ezetimibe—ABCB1—digestive system—malaria	0.000276	0.00155	CbGeAlD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—CD36—malaria	0.000275	0.00279	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—DHODH—malaria	0.000273	0.00277	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.00027	0.00274	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—G6PD—malaria	0.000268	0.00272	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—CD36—malaria	0.000264	0.00268	CbGpPWpGaD
Ezetimibe—ABCB1—blood—malaria	0.000263	0.00147	CbGeAlD
Ezetimibe—NPC1L1—Metabolism—DHFR—malaria	0.00026	0.00264	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—HPGDS—malaria	0.000259	0.00263	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—SCARB1—malaria	0.000257	0.00261	CbGpPWpGaD
Ezetimibe—ABCB1—bone marrow—malaria	0.000255	0.00143	CbGeAlD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000253	0.00257	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000241	0.00244	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.00024	0.00243	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—SLC4A1—malaria	0.000232	0.00235	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC4A1—malaria	0.000226	0.00229	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—NOS2—malaria	0.000224	0.00227	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000223	0.00226	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—DECR1—malaria	0.000218	0.00221	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—HPGDS—malaria	0.000212	0.00215	CbGpPWpGaD
Ezetimibe—ABCB1—liver—malaria	0.000206	0.00115	CbGeAlD
Ezetimibe—ABCG5—Metabolism—HPGDS—malaria	0.000204	0.00207	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—HBB—malaria	0.000197	0.002	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—DHFR—malaria	0.000197	0.002	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—SCARB1—malaria	0.000195	0.00198	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—DHFR—malaria	0.00019	0.00192	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—SCARB1—malaria	0.000188	0.0019	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL12B—malaria	0.000187	0.0019	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000179	0.00182	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PKLR—malaria	0.000176	0.00178	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000175	0.00177	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000168	0.00171	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000166	0.00169	CbGpPWpGaD
Ezetimibe—ABCB1—brain—malaria	0.000163	0.000915	CbGeAlD
Ezetimibe—NPC1L1—Metabolism—CD36—malaria	0.000161	0.00164	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—G6PD—malaria	0.000157	0.00159	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000156	0.00158	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—DHODH—malaria	0.000146	0.00148	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL10—malaria	0.000137	0.00139	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CD40LG—malaria	0.000137	0.00139	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL4—malaria	0.000133	0.00135	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—HLA-B—malaria	0.00013	0.00132	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DHODH—malaria	0.000124	0.00126	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SLC4A1—malaria	0.000124	0.00126	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DHODH—malaria	0.000124	0.00126	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—FAS—malaria	0.000123	0.00124	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CD36—malaria	0.000122	0.00124	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000122	0.00124	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	0.000121	0.00123	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—HPGDS—malaria	0.00012	0.00121	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CD36—malaria	0.000118	0.00119	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—DECR1—malaria	0.000117	0.00119	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000112	0.00114	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—DHFR—malaria	0.000111	0.00113	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—SCARB1—malaria	0.00011	0.00111	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000109	0.00111	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—HBB—malaria	0.000106	0.00107	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC4A1—malaria	0.000106	0.00107	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC4A1—malaria	0.000106	0.00107	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DHODH—malaria	0.000101	0.00103	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DECR1—malaria	9.94e-05	0.00101	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DECR1—malaria	9.94e-05	0.00101	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PKLR—malaria	9.43e-05	0.000956	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DHODH—malaria	9.26e-05	0.000939	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—malaria	9.11e-05	0.000924	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—HBB—malaria	8.99e-05	0.000912	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—HBB—malaria	8.99e-05	0.000912	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC4A1—malaria	8.59e-05	0.000872	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DHODH—malaria	8.58e-05	0.00087	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	8.42e-05	0.000854	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—G6PD—malaria	8.4e-05	0.000852	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—malaria	8.36e-05	0.000848	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DECR1—malaria	8.08e-05	0.000819	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IFNG—malaria	8.04e-05	0.000815	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PKLR—malaria	8.02e-05	0.000813	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PKLR—malaria	8.02e-05	0.000813	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC4A1—malaria	7.88e-05	0.000799	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DECR1—malaria	7.4e-05	0.000751	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—HPGDS—malaria	7.32e-05	0.000742	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HBB—malaria	7.31e-05	0.000741	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC4A1—malaria	7.29e-05	0.000739	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL1B—malaria	7.17e-05	0.000727	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2—malaria	7.14e-05	0.000725	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—G6PD—malaria	7.14e-05	0.000724	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—G6PD—malaria	7.14e-05	0.000724	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CD36—malaria	7.05e-05	0.000715	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CD36—malaria	6.89e-05	0.000699	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DECR1—malaria	6.86e-05	0.000695	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HBB—malaria	6.7e-05	0.000679	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PKLR—malaria	6.51e-05	0.000661	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—HPGDS—malaria	6.41e-05	0.00065	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HBB—malaria	6.2e-05	0.000629	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	6.05e-05	0.000613	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PKLR—malaria	5.97e-05	0.000605	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—DHFR—malaria	5.94e-05	0.000603	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SCARB1—malaria	5.88e-05	0.000597	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—G6PD—malaria	5.81e-05	0.000589	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PKLR—malaria	5.53e-05	0.00056	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—HPGDS—malaria	5.45e-05	0.000553	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—HPGDS—malaria	5.45e-05	0.000553	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—G6PD—malaria	5.32e-05	0.000539	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—malaria	5.25e-05	0.000532	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—malaria	5.2e-05	0.000528	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DHFR—malaria	5.05e-05	0.000513	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DHFR—malaria	5.05e-05	0.000513	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SCARB1—malaria	5e-05	0.000507	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SCARB1—malaria	5e-05	0.000507	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—G6PD—malaria	4.93e-05	0.0005	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DHODH—malaria	4.64e-05	0.00047	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HPGDS—malaria	4.43e-05	0.000449	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DHFR—malaria	4.11e-05	0.000417	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SCARB1—malaria	4.06e-05	0.000412	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HPGDS—malaria	4.06e-05	0.000411	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC4A1—malaria	3.94e-05	0.0004	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DHFR—malaria	3.76e-05	0.000382	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HPGDS—malaria	3.76e-05	0.000381	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SCARB1—malaria	3.72e-05	0.000378	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DECR1—malaria	3.71e-05	0.000376	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CD36—malaria	3.69e-05	0.000374	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DHFR—malaria	3.48e-05	0.000353	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SCARB1—malaria	3.45e-05	0.00035	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HBB—malaria	3.35e-05	0.00034	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CD36—malaria	3.14e-05	0.000318	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CD36—malaria	3.14e-05	0.000318	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PKLR—malaria	2.99e-05	0.000303	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DHODH—malaria	2.86e-05	0.00029	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—G6PD—malaria	2.66e-05	0.00027	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.57e-05	0.00026	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CD36—malaria	2.55e-05	0.000259	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC4A1—malaria	2.43e-05	0.000246	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CD36—malaria	2.34e-05	0.000237	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DECR1—malaria	2.28e-05	0.000232	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CD36—malaria	2.16e-05	0.000219	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HBB—malaria	2.07e-05	0.000209	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HPGDS—malaria	2.03e-05	0.000206	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DHFR—malaria	1.88e-05	0.000191	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SCARB1—malaria	1.86e-05	0.000189	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PKLR—malaria	1.84e-05	0.000187	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—G6PD—malaria	1.64e-05	0.000166	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HPGDS—malaria	1.25e-05	0.000127	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CD36—malaria	1.17e-05	0.000119	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DHFR—malaria	1.16e-05	0.000118	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SCARB1—malaria	1.15e-05	0.000117	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CD36—malaria	7.21e-06	7.31e-05	CbGpPWpGaD
